Full-Time

Sr. Product Marketing Manager

Posted on 8/20/2024

Radformation

Radformation

51-200 employees

Healthcare software for radiation therapy planning

Compensation Overview

$150k - $155k/yr

Expert

Remote in USA

Category
General Marketing
Growth Marketing
Growth & Marketing
Required Skills
Market Research
Sales
Marketing
Requirements
  • Bachelor’s degree in Marketing, Business, related field or equivalent experience
  • 10+ years of product marketing experience in the radiation oncology industry, plus for additional experience in EMEA market
  • Exceptional written and verbal communication skills
  • Strong project management skills
  • Self motivated, collaborative, creative and analytical
  • Strong interpersonal skills
  • Some travel required
Responsibilities
  • Gain a deep understanding of the Radformation suite, vision and future roadmap and utilize storytelling skills to translate the value into compelling narratives that resonate with various segments.
  • Conduct market research to gather intelligence on customer preferences, market dynamics, and competitive positioning.
  • Analyze market data to identify opportunities for product differentiation and market expansion.
  • Develop presentations and materials that simplify intricate concepts and highlight the benefits of our products.
  • Works as a bridge between product management and customer to gather feedback to inform product improvements and innovation.
  • Participate in planning and execution of product launches, including go-to-market strategies.
  • Empower the sales team with competitive analysis, training and strategies to enhance their product knowledge and position our products effectively against competitors.
  • Collaborate with R&D, sales, and regulatory teams to ensure successful product introductions.
  • Build and maintain strong relationships with key customers, industry influencers, and thought leaders.

Radformation provides software tools for the healthcare technology sector, specifically aimed at improving the treatment planning process for radiation therapy. Their products, which include ClearCheck for automating plan checks, ClearCalc for dose validation, EZFluence for creating 3D treatment plans, AutoContour for AI-driven contouring, ChartCheck for monitoring patient data, and QuickCode for billing quality assurance, are designed to integrate smoothly into existing workflows at clinics. Unlike many competitors, Radformation focuses on automating various aspects of treatment planning, which helps clinics save time and resources while maintaining high standards of patient care. The company's goal is to enhance the efficiency and quality of radiation therapy treatment planning through their FDA-cleared software solutions.

Company Size

51-200

Company Stage

Early VC

Total Funding

$9.2M

Headquarters

New York City, New York

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Limbus AI enhances Radformation's AI-driven capabilities in cancer care.
  • Partnership with Icon Group expands global reach and transforms cancer treatment workflows.
  • Upcoming AutoContour v2.6 release demonstrates commitment to continuous product innovation.

What critics are saying

  • Emerging AI-driven startups may challenge Radformation's market position with competitive solutions.
  • Rapid AI advancements could render Radformation's existing products obsolete.
  • Data privacy concerns and regulatory scrutiny may impact Radformation's operations and reputation.

What makes Radformation unique

  • Radformation automates radiation therapy workflows, reducing planning errors and saving time.
  • Their FDA-cleared software tools enhance treatment planning efficiency and quality.
  • Key products include ClearCheck, ClearCalc, EZFluence, AutoContour, ChartCheck, and QuickCode.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Parental Leave

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

12%

2 year growth

12%
Radformation
Jan 7th, 2025
Upcoming Release: AutoContour v2.6 Offers 95 Brand New Structure Models

Radformation is thrilled to announce the upcoming release of AutoContour v2.6, packed with exciting features, enhancements, and additional structure models.

Business Wire
May 3rd, 2024
Radformation to Accelerate AI-Based Solutions with Limbus AI Acquisition

Radformation, Inc. has acquired Limbus AI. This merger combines their strengths to advance AI-driven solutions, aiming to enhance patient care.

Business Wire
May 1st, 2024
Radformation To Accelerate Ai-Based Solutions With Limbus Ai Acquisition

NEW YORK--(BUSINESS WIRE)--Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired privately-held Limbus AI, a leading global provider of automated contouring software for radiation therapy. This acquisition signifies Radformation’s commitment to driving innovation and expanding its AI-driven capabilities in cancer care. “Our mission has always been to improve the radiation therapy process, focusing on efficiency, quality, and safety in patient care,” said Kurt Sysock, CEO of Radformation. “With Limbus' innovative technology and expertise now part of our team, we are even more equipped to advance the frontier of innovative software solutions in radiation therapy.”. This merger aims to harness the collective strengths of both companies' platforms by integrating the superior features of each system, offering the most advanced AI-driven contouring solution available today. Beyond improving contouring, this effort is expected to spark further innovation, leading to new developments and improvements in radiation therapy

Business Wire
Feb 22nd, 2024
Radformation Recebe Autorizações Regulatórias Para Soluções De Automação Na Austrália, Brasil, Canadá E Tailândia

NOVA YORK--(BUSINESS WIRE)--Radformation, líder em soluções de software clínico e operacional para tratamento do câncer, anunciou hoje que recebeu autorizações regulatórias para suas soluções de automação de radioterapia* da Therapeutic Goods Administration (TGA) na Austrália, da Agência Nacional de Vigilância Sanitária (ANVISA) no Brasil, da Health Canada no Canadá e da Administração de Alimentos e Medicamentos (FDA) na Tailândia. “Essas autorizações refletem nosso compromisso com a inovação global em saúde e nossa dedicação em atender aos rigorosos padrões regulatórios essenciais para melhorar o atendimento aos pacientes no mundo inteiro”, disse Kurt Sysock, CEO da Radformation. Incluído nessas autorizações está o AutoContour, a solução de segmentação e perfilamento automática baseada em IA da Radformation, projetado para iniciar o processo de planejamento do tratamento. Em um estudo de caso recente, o AutoContour demonstrou diminuir o tempo de planejamento do perfilamento em uma média de 84% em todos os locais anatômicos, gerando perfilamentos altamente precisos, levando a uma melhor consistência do plano de tratamento. Os primeiros usuários brasileiros do AutoContour e do ClearCheck, o software automatizado de verificação de plano secundário da Radformation, a Liga Catarinense de Combate ao Câncer - Radioterapia São Sebastião e o Real Hospital Português de Beneficência, selecionaram as ferramentas da Radformation para complementar suas crescentes modalidades de tratamento de última geração e expandir a carga de pacientes

Business Wire
Feb 22nd, 2024
Radformation Receives Regulatory Clearances For Automation Solutions In Australia, Brazil, Canada, And Thailand

NEW YORK--(BUSINESS WIRE)--Radformation, a leader in clinical and operational software solutions for cancer care, announced today that it has received regulatory clearances for its radiotherapy automation solutions* from the Therapeutic Goods Administration (TGA) in Australia, the National Health Surveillance Agency (ANVISA) in Brazil, Health Canada and the Thai Food and Drug Administration (FDA). “These clearances reflect our commitment to global healthcare innovation and our dedication to meet the rigorous regulatory standards essential to improve patient care worldwide” said Kurt Sysock, CEO of Radformation. Included in these clearances is AutoContour, Radformation’s AI-driven auto-segmentation and contouring solution designed to jump start the treatment planning process. In a recent case study, AutoContour was shown to decrease contour planning time by an average of 84% across all anatomical sites, generate highly accurate contours, leading to improved treatment plan consistency. Early Brazilian adopters of AutoContour and ClearCheck, Radformation’s automated secondary plan check software, Liga Catarinense de Combate ao Câncer - Radioterapia São Sebastião and Real Hospital Português de Beneficência selected Radformation’s tools to complement their growing state of the art treatment modalities and expanding patient load

INACTIVE